Literature DB >> 18493852

Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes.

Soon Young Lee1, Hee Jin Kim, Woo Jong Lee, So Hyun Joo, Se-Jin Jeon, Ji Woon Kim, Hee Sun Kim, Seol-Heui Han, Jongmin Lee, Seung Hwa Park, Jae Hoon Cheong, Won-Ki Kim, Kwang Ho Ko, Chan Young Shin.   

Abstract

We investigated the effect of the cAMP system on lipopolysaccharide (LPS)-induced changes in the activity of matrix metalloproteinases (MMPs) and tissue plasminogen activator (tPA) in rat primary astrocytes. LPS stimulation increased MMP-9 and decreased tPA activity in rat primary astrocytes. Co-treatment with a cAMP analog, dibutyryl-cAMP (db-cAMP), or the cAMP elevating beta-adrenergic agonist, isoproterenol, concentration-dependently inhibited LPS-induced MMP-9 activity. In contrast, db-cAMP concentration-dependently increased tPA activity in both basal and LPS-stimulated rat primary astrocytes. To confirm the effect of cAMP on MMP-9 and tPA activity, we treated LPS-stimulated astrocytes with cAMP phosphodiesterase inhibitors, IBMX or rolipram, and they exhibited similar effects to db-cAMP, namely decreasing MMP-9 activity and increasing tPA activity. RT-PCR analysis of MMP-9 mRNA expression and MMP-9 promoter luciferase reporter assays revealed transcriptional upregulation by LPS stimulation and downregulation by db-cAMP. In contrast, the level of tPA mRNA expression was increased both by LPS and by cAMP treatment. Consistent with RT-PCR analysis, tPA promoter reporter assays showed increased activity by both LPS and cAMP stimulation. Interestingly, the level of mRNA encoding plasminogen activator inhibitor-1 (PAI-1) was increased by LPS stimulation and decreased back to control level after co-treatment with db-cAMP, suggesting that PAI-1 expression plays a major role in the regulation of tPA activity. To examine PKA involvement in the effects of db-cAMP on MMP-9 and tPA activity, we added the PKA inhibitors, H89 or rp-cAMP, along with db-cAMP, and they inhibited db-cAMP-mediated changes in tPA activity without affecting MMP-9 activity. These data suggest that cAMP differentially modulates MMP-9 and tPA activity through a mechanism related to PKA activation. The differential regulation of MMP-9 and tPA by the cAMP system may confer more sophisticated regulation of physiological processes, such as extracellular matrix remodeling and cell migration, by activated astrocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493852     DOI: 10.1007/s11064-008-9737-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  62 in total

1.  mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation.

Authors:  T Masos; R Miskin
Journal:  Brain Res Mol Brain Res       Date:  1997-07

Review 2.  Matrix metalloproteinases: useful and deleterious.

Authors:  E Ganea; M Trifan; A C Laslo; G Putina; C Cristescu
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

3.  Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.

Authors:  E Galea; D L Feinstein; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

Authors:  Ping Yan; Xiaoyan Hu; Haowei Song; Kejie Yin; Randall J Bateman; John R Cirrito; Qingli Xiao; Fong F Hsu; John W Turk; Jan Xu; Chung Y Hsu; David M Holtzman; Jin-Moo Lee
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

5.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

6.  Immunostimulation of rat primary astrocytes decreases intracellular ATP level.

Authors:  C Y Shin; J W Choi; J R Ryu; J H Ryu; W Kim; H Kim; K H Ko
Journal:  Brain Res       Date:  2001-06-01       Impact factor: 3.252

7.  Is tissue-type plasminogen activator a neuromodulator?

Authors:  Mónica Fernández-Monreal; José P López-Atalaya; Karim Benchenane; Frederic Léveillé; Mathias Cacquevel; Laurent Plawinski; Eric T MacKenzie; Guojun Bu; Alain Buisson; Denis Vivien
Journal:  Mol Cell Neurosci       Date:  2004-04       Impact factor: 4.314

8.  TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase.

Authors:  G A Rosenberg; M Kornfeld; E Estrada; R O Kelley; L A Liotta; W G Stetler-Stevenson
Journal:  Brain Res       Date:  1992-04-03       Impact factor: 3.252

9.  Cyclic adenosine 3',5'-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts.

Authors:  S Takahashi; A Ito; M Nagino; Y Mori; B Xie; H Nagase
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

10.  In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues.

Authors:  I B Kingston; M J Castro; S Anderson
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

View more
  8 in total

1.  Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9.

Authors:  Sun Mi Shin; Kyu Suk Cho; Min Sik Choi; Sung Hoon Lee; Seol-Heui Han; Young-Sun Kang; Hee Jin Kim; Jae Hoon Cheong; Chan Young Shin; Kwang Ho Ko
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

Review 2.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 3.  Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.

Authors:  Denis Vivien; Maxime Gauberti; Axel Montagne; Gilles Defer; Emmanuel Touzé
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-31       Impact factor: 6.200

4.  Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.

Authors:  Benoit D Roussel; Richard Macrez; Amandine Jullienne; Véronique Agin; Eric Maubert; Luce Dauphinot; Marie-Claude Potier; Laurent Plawinski; Hervé Castel; Yannick Hommet; Josep Munuera; Joan Montaner; Manuel Yepes; Carine Ali; Denis Vivien
Journal:  Brain       Date:  2009-07-02       Impact factor: 13.501

5.  The Effector Protein BPE005 from Brucella abortus Induces Collagen Deposition and Matrix Metalloproteinase 9 Downmodulation via Transforming Growth Factor β1 in Hepatic Stellate Cells.

Authors:  Paula Constanza Arriola Benitez; Diego Rey Serantes; Claudia Karina Herrmann; Ayelén Ivana Pesce Viglietti; Silvia Vanzulli; Guillermo Hernán Giambartolomei; Diego José Comerci; María Victoria Delpino
Journal:  Infect Immun       Date:  2015-12-14       Impact factor: 3.441

6.  Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG132.

Authors:  Kyu Suk Cho; Kyoung Ja Kwon; Se Jin Jeon; So Hyun Joo; Ki Chan Kim; Jae Hoon Cheong; Geon Ho Bahn; Hahn Young Kim; Seol Heui Han; Chan Young Shin; Sung-Il Yang
Journal:  Biomol Ther (Seoul)       Date:  2013-03       Impact factor: 4.634

7.  Fluoroquinolones Suppress TGF-β and PMA-Induced MMP-9 Production in Cancer Cells: Implications in Repurposing Quinolone Antibiotics for Cancer Treatment.

Authors:  Cheng-Yi Huang; Jenq-Lin Yang; Jih-Jung Chen; Shun-Ban Tai; Yu-Hsuan Yeh; Pei-Feng Liu; Ming-Wei Lin; Chih-Ling Chung; Chun-Lin Chen
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

8.  Effects of Korean Red Ginseng extract on tissue plasminogen activator and plasminogen activator inhibitor-1 expression in cultured rat primary astrocytes.

Authors:  Hyun Myung Ko; So Hyun Joo; Pitna Kim; Jin Hee Park; Hee Jin Kim; Geon Ho Bahn; Hahn Young Kim; Jongmin Lee; Seol-Heui Han; Chan Young Shin; Seung Hwa Park
Journal:  J Ginseng Res       Date:  2013-10       Impact factor: 6.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.